Updated hourlyHourly refreshWed, Jul 22, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pentair plc ("Pentair" or "the Company") (NYSE:PNR). Investors who purchased Pentair securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/PNR. Pentair Investigation Details On July 14, 2026, Pentair issued a press release announcing its preliminary second quarter 2026 financial results and revising its full year 2026 guidance. For the second quarter, Pentair reported that "[s]ales are expected to be approximately $930 million, down 17 percent versus previous guide of ..
Jul 21 · 15:04·PR-Inside
Finance · AI
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AppLovin Corporation ("AppLovin" or "the Company") (NASDAQ:APP). Investors who purchased AppLovin securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/APP. AppLovin Investigation Details On July 13, 2026, a Bank of America Securities analyst published a note reporting softer-than-expected e-commerce ad growth for the month of June, raising concerns over the rollout of AppLovin's new AI-driven merchant platform. Following publication of the note, AppLovin's stock price fell $64.13 per share, ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of International Business Machines Corporation ("IBM" or "the Company") (NYSE:IBM). Investors who purchased IBM securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/IBM. IBM Investigation Details On July 14, 2026, IBM reported its preliminary Q2 2026 financial results. The Company fell short of analyst expectations, with CEO Arvind Krishna blaming the shortfall on weakness in the software and infrastructure business, with customers shifting budgets to hardware like memory chips. Following ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AstraZeneca PLC ("AstraZeneca" or "the Company") (NYSE:AZN). Investors who purchased AstraZeneca securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/AZN. AstraZeneca Investigation Details On July 9, 2026, AstraZeneca disclosed that the late-stage Phase-3 CARDIO-TTransform trial of Wainua, an amyloid cardiomyopathy treatment developed in collaboration with Ionis Pharmaceuticals, did not meet its primary endpoint. Following this news, AstraZeneca's American Depositary Share ("ADS") price fell $10.79 per ADS, or 5.7%, to ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ionis Pharmaceuticals, Inc. ("Ionis" or "the Company") (NASDAQ:IONS). Investors who purchased Ionis securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/IONS. Ionis Investigation Details On July 9, 2026, Ionis disclosed that the late-stage Phase-3 CARDIO-TTransform trial of Wainua, an amyloid cardiomyopathy treatment developed in collaboration with AstraZeneca, did not meet its primary endpoint. Following this news, Ionis's stock price fell $20.19 per share, or 23.9%, to close at $64.27 ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snowflake Inc. ("Snowflake Inc." or "the Company") (NYSE:SNOW). Investors who purchased Snowflake Inc. securities prior to June 27, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/SNOW. Snowflake Inc. Investigation Details The investigation concerns whether Snowflake Inc. and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Snowflake Inc. Investors? If you are aware of any facts relating to ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin Covey Co. ("Franklin Covey" or "the Company") (NYSE:FC). Investors who purchased Franklin Covey securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/FC. Franklin Covey Investigation Details On July 1, 2026, Franklin Covey issued a press release reporting its financial results for the third quarter of its 2026 fiscal year. Among other items, Franklin Covey reported revenue of only $67.81 million, missing the consensus estimate of $68.33 million, and ..
Jul 21 · 15:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. ("Solstice" or "the Company") (NASDAQ:SOLS). Investors who purchased Solstice securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/SOLS. Solstice Investigation Details On July 6, 2026, Solstice issued a press release announcing an agreement to acquire Element Solutions ("Element") "in a cash-and-stock transaction valued at approximately $14.5 billion, including the assumption of net debt." Although Solstice's Chief Executive Officer described the "combined company [as] very well-positioned ..
Jul 21 · 15:03·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Graphic Packaging Holding Company ("Graphic Packaging" or "the Company") (NYSE:GPK). Investors who purchased Graphic Packaging securities prior to February 4, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GPK. Graphic Packaging Investigation Details The investigation concerns whether Graphic Packaging and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Graphic Packaging Investors? If you are aware of any ..
Jul 21 · 15:03·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Concentrix Corporation ("Concentrix" or "the Company") (NASDAQ:CNXC). Investors who purchased Concentrix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/CNXC. Concentrix Investigation Details On June 29, 2026, Concentrix reported its Q2 2026 financial results. The Company's results missed analyst consensus estimates, and it also slashed its full-year outlook. Following this news, Concentrix's stock price dropped the next day. What's Next for Concentrix Investors? If you are aware of any facts relating ..
Jul 21 · 15:03·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. ("Alignment" or "the Company") (NASDAQ:ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/ALHC. Alignment Investigation Details On July 8, 2026, Modern Healthcare reported that a former Alignment executive had filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation. Specifically, the lawsuit claims that Alignment deliberately misclassified routine operating expenses (such as ..
Jul 21 · 15:03·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ:UNCY). Investors who purchased Unicycive securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/UNCY. Unicycive Investigation Details On June 30, 2026, Unicycive disclosed that the FDA had issued a second Complete Response Letter ("CRL") regarding the Company's resubmitted New Drug Application for its kidney disease therapy, oxylanthanum, identifying the "same third-party manufacturing deficiencies that were identified in the previous CRL issued in ..
Jul 21 · 15:03·PR-Inside